Insulin receptor substrate-1 associates with small nucleolar RNA which contributes to ribosome biogenesis

Frontiers in Endocrinology

Volumn 5, Issue MAR, 2014, Pages

  Ozoe, Atsufumi ^a   Sone, Meri ^a   Fukushima, Toshiaki ^a,b   Kataoka, Naoyuki ^c   Chida, Kazuhiro ^a   Asano, Tomoichiro ^b   Hakuno, Fumihiko ^a   Takahashi, Shin Ichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Insulin receptor substrate; Insulin like growth factor; RACK1; SnoRNA; U96A

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MESSENGER RNA; MESSENGER RNA PRECURSOR; RECEPTOR FOR ACTIVATED C KINASE 1; SMALL NUCLEOLAR RNA; SOMATOMEDIN; UNTRANSLATED RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOGENESIS; CELL FRACTIONATION; CELL NUCLEUS; COILED BODY; CONTROLLED STUDY; CROSS LINKING; CYTOPLASM; DNA CONTENT; FLUORESCENCE ACTIVATED CELL SORTING; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; IN VITRO STUDY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBOSOME; RNA EXTRACTION; RNA SYNTHESIS; SEQUENCE ANALYSIS; ULTRAVIOLET RADIATION;

EID: 84901058227     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00024     Document Type: Article

References (58)

1. Clayton PE, Banerjee I, Murray PG, Renehan AG. Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat Rev Endocrinol (2010) 7(1):11-24. doi:10.1038/nrendo.2010.171.
2. Copps KD, White MF. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia (2012) 55(10):2565-82. doi:10.1007/s00125-012-2644-8.
3. Sun XJ, Miralpeix M, Myers MG Jr, Glasheen EM, Backer JM, Kahn CR, et al. Expression and function of IRS-1 in insulin signal transmission. J Biol Chem (1992) 267(31):22662-72.
4. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MG Jr, Glasheen E, et al. Role of IRS-2 in insulin and cytokine signalling. Nature (1995) 377(6545):173-7. doi:10.1038/377173a0.
5. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature (1998) 391(6670):900-4. doi:10.1038/36116.
6. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B III, Johnson RS, et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature (1994) 372(6502):186-90. doi:10.1038/372186a0.
7. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature (1994) 372(6502):182-6. doi:10.1038/372182a0.
8. Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet (2006) 7(8):606-19. doi:10.1038/nrg1879.
9. Mayer C, Grummt I. Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene (2006) 25(48):6384-91. doi:10.1038/sj.onc.1209883.
10. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell (2006) 124(3):471-84. doi:10.1016/j.cell.2006.01.016.
11. Tanaka S, Wands JR. A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype. J Clin Invest (1996) 98(9):2100-8. doi:10.1172/JCI119016.
12. Bergmann U, Funatomi H, Kornmann M, Beger HG, Korc M. Increased expression of insulin receptor substrate-1 in human pancreatic cancer. Biochem Biophys Res Commun (1996) 220(3):886-90. doi:10.1006/bbrc.1996.0500.
13. Chang Q, Li Y, White MF, Fletcher JA, Xiao S. Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications. Cancer Res (2002) 62(21):6035-8.
14. van Riggelen J, Yetil A, Felsher DW. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer (2010) 10(4):301-9. doi:10.1038/nrc2819.
15. Doudna JA, Rath VL. Structure and function of the eukaryotic ribosome: the next frontier. Cell (2002) 109(2):153-6. doi:10.1016/S0092-8674(02)00725-0.
16. Rodnina MV, Wintermeyer W. Recent mechanistic insights into eukaryotic ribosomes. Curr Opin Cell Biol (2009) 21(3):435-43. doi:10.1016/j.ceb.2009.01.023.
17. Kiss T. Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular functions. Cell (2002) 109(2):145-8. doi:10.1016/S0092-8674(02)00718-3.
18. Tran E, Brown J, Maxwell ES. Evolutionary origins of the RNA-guided nucleotide-modification complexes: from the primitive translation apparatus? Trends Biochem Sci (2004) 29(7):343-50. doi:10.1016/j.tibs.2004.05.001.
19. Kiss T, Fayet E, Jady BE, Richard P, Weber M. Biogenesis and intranuclear trafficking of human box C/D and H/ACA RNPs. Cold Spring Harb Symp Quant Biol (2006) 71:407-17. doi:10.1101/sqb.2006.71.025.
20. Weinstein LB, Steitz JA. Guided tours: from precursor snoRNA to functional snoRNP. Curr Opin Cell Biol (1999) 11(3):378-84. doi:10.1016/S0955-0674(99)80053-2.
21. Hirose T, Ideue T, Nagai M, Hagiwara M, Shu MD, Steitz JA. A spliceosomal intron binding protein, IBP160, links position-dependent assembly of intron-encoded box C/D snoRNP to pre-mRNA splicing. Mol Cell (2006) 23(5):673-84. doi:10.1016/j.molcel.2006.07.011.
22. Hirose T, Shu MD, Steitz JA. Splicing-dependent and-independent modes of assembly for intron-encoded box C/D snoRNPs in mammalian cells. Mol Cell (2003) 12(1):113-23. doi:10.1016/S1097-2765(03)00267-3.
23. Tycowski KT, Shu MD, Steitz JA. A small nucleolar RNA is processed from an intron of the human gene encoding ribosomal protein S3. Genes Dev (1993) 7(7A):1176-90. doi:10.1101/gad.7.7a.1176.
24. Cavaille J, Bachellerie JP. Processing of fibrillarin-associated snoRNAs from pre-mRNA introns: an exonucleolytic process exclusively directed by the common stem-box terminal structure. Biochimie (1996) 78(6):443-56. doi:10.1016/0300-9084(96)84751-1.
25. Ooi SL, Samarsky DA, Fournier MJ, Boeke JD. Intronic snoRNA biosynthesis in Saccharomyces cerevisiae depends on the lariat-debranching enzyme: intron length effects and activity of a precursor snoRNA. RNA (1998) 4(9):1096-110. doi:10.1017/S1355838298980785.
26. Williams GT, Farzaneh F. Are snoRNAs and snoRNA host genes new players in cancer? Nat Rev Cancer (2012) 12(2):84-8. doi:10.1038/nrc3195.
27. Montanaro L, Trere D, Derenzini M. Nucleolus, ribosomes, and cancer. Am J Pathol (2008) 173(2):301-10. doi:10.2353/ajpath.2008.070752.
28. Shiue CN, Berkson RG, Wright AP. c-Myc induces changes in higher order rDNA structure on stimulation of quiescent cells. Oncogene (2009) 28(16):1833-42. doi:10.1038/onc.2009.21.
29. Fukushima T, Arai T, Ariga-Nedachi M, Okajima H, Ooi Y, Iijima Y, et al. Insulin receptor substrates form high-molecular-mass complexes that modulate their availability to insulin/insulin-like growth factor-I receptor tyrosine kinases. Biochem Biophys Res Commun (2010) 404(3):767-73. doi:10.1016/j.bbrc.2010.12.045.
30. Ozoe A, Sone M, Fukushima T, Kataoka N, Arai T, Chida K, et al. Insulin receptor substrate-1 (IRS-1) forms a ribonucleoprotein complex associated with polysomes. FEBS Lett (2013) 587(15):2319-24. doi:10.1016/j.febslet.2013.05.066.
31. Ariga M, Nedachi T, Akahori M, Sakamoto H, Ito Y, Hakuno F, et al. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells. Biochem J (2000) 348(Pt 2):409-16. doi:10.1042/0264-6021:3480409.
32. Hakuno F, Kurihara S, Watson RT, Pessin JE, Takahashi S. 53BP2S, interacting with insulin receptor substrates, modulates insulin signaling. J Biol Chem (2007) 282(52):37747-58. doi:10.1074/jbc. M702472200.
33. Kabuta T, Hakuno F, Asano T, Takahashi S. Insulin receptor substrate-3 functions as transcriptional activator in the nucleus. J Biol Chem (2002) 277(9):6846-51. doi:10.1074/jbc. M107058200.
34. Robertson EJ. Teratocarcinomas and embryonic stem cells: a practical approach edited by E.J. Robertson. IRL Press, Oxford, 71-112 (1987).
35. Ule J, Jensen K, Mele A, Darnell RB. CLIP: a method for identifying protein-RNA interaction sites in living cells. Methods (2005) 37(4):376-86. doi:10.1016/j.ymeth.2005.07.018.
36. Ninomiya K, Kataoka N, Hagiwara M. Stress-responsive maturation of Clk1/4 pre-mRNAs promotes phosphorylation of SR splicing factor. J Cell Biol (2011) 195(1):27-40. doi:10.1083/jcb.201107093.
37. Ule J, Jensen KB, Ruggiu M, Mele A, Ule A, Darnell RB. CLIP identifies Nova-regulated RNA networks in the brain. Science (2003) 302(5648):1212-5. doi:10.1126/science.1090095.
38. Vitali P, Royo H, Seitz H, Bachellerie JP, Huttenhofer A, Cavaille J. Identification of 13 novel human modification guide RNAs. Nucleic Acids Res (2003) 31(22):6543-51. doi:10.1093/nar/gkg849.
39. Watkins NJ, Dickmanns A, Luhrmann R. Conserved stem II of the box C/D motif is essential for nucleolar localization and is required, along with the 15.5K protein, for the hierarchical assembly of the box C/D snoRNP. Mol Cell Biol (2002) 22(23):8342-52. doi:10.1128/MCB.22.23.8342-8352.2002.
40. Izaurralde E, Lewis J, McGuigan C, Jankowska M, Darzynkiewicz E, Mattaj IW. A nuclear cap binding protein complex involved in pre-mRNA splicing. Cell (1994) 78(4):657-68. doi:10.1016/0092-8674(94)90530-4.
41. Kataoka N, Ohno M, Kangawa K, Tokoro Y, Shimura Y. Cloning of a complementary DNA encoding an 80 kilodalton nuclear cap binding protein. Nucleic Acids Res (1994) 22(19):3861-5. doi:10.1093/nar/22.19.3861.
42. Shaw PJ, Beven AF, Leader DJ, Brown JW. Localization and processing from a polycistronic precursor of novel snoRNAs in maize. J Cell Sci (1998) 111(Pt 15):2121-8.
43. Chen J, Wu A, Sun H, Drakas R, Garofalo C, Cascio S, et al. Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and beta-catenin. J Biol Chem (2005) 280(33):29912-20. doi:10.1074/jbc. M504516200.
44. Lassak A, Del Valle L, Peruzzi F, Wang JY, Enam S, Croul S, et al. Insulin receptor substrate 1 translocation to the nucleus by the human JC virus T-antigen. J Biol Chem (2002) 277(19):17231-8. doi:10.1074/jbc. M110885200.
45. Morelli C, Garofalo C, Sisci D, del Rincon S, Cascio S, Tu X, et al. Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters. Oncogene (2004) 23(45):7517-26. doi:10.1038/sj.onc.1208014.
46. Prisco M, Santini F, Baffa R, Liu M, Drakas R, Wu A, et al. Nuclear translocation of insulin receptor substrate-1 by the simian virus 40 T antigen and the activated type 1 insulin-like growth factor receptor. J Biol Chem (2002) 277(35):32078-85. doi:10.1074/jbc. M204658200.
47. Sun H, Tu X, Prisco M, Wu A, Casiburi I, Baserga R. Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2. Mol Endocrinol (2003) 17(3):472-86. doi:10.1210/me.2002-0276.
48. Tu X, Batta P, Innocent N, Prisco M, Casaburi I, Belletti B, et al. Nuclear translocation of insulin receptor substrate-1 by oncogenes and IGF-I. Effect on ribosomal RNA synthesis. J Biol Chem (2002) 277(46):44357-65. doi:10.1074/jbc. M208001200.
49. Yoon JC, Ng A, Kim BH, Bianco A, Xavier RJ, Elledge SJ. Wnt signaling regulates mitochondrial physiology and insulin sensitivity. Genes Dev (2010) 24(14):1507-18. doi:10.1101/gad.1924910.
50. Kralovicova J, Hwang G, Asplund AC, Churbanov A, Smith CI, Vorechovsky I. Compensatory signals associated with the activation of human GC 5' splice sites. Nucleic Acids Res (2011) 39(16):7077-91. doi:10.1093/nar/gkr306.
51. Thanaraj TA, Clark F. Human GC-AG alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions. Nucleic Acids Res (2001) 29(12):2581-93. doi:10.1093/nar/29.12.2581.
52. Omer AD, Ziesche S, Ebhardt H, Dennis PP. In vitro reconstitution and activity of a C/D box methylation guide ribonucleoprotein complex. Proc Natl Acad Sci U S A (2002) 99(8):5289-94. doi:10.1073/pnas.082101999.
53. Tollervey D, Lehtonen H, Jansen R, Kern H, Hurt EC. Temperature-sensitive mutations demonstrate roles for yeast fibrillarin in pre-rRNA processing, pre-rRNA methylation, and ribosome assembly. Cell (1993) 72(3):443-57. doi:10.1016/0092-8674(93)90120-F.
54. Jack K, Bellodi C, Landry DM, Niederer RO, Meskauskas A, Musalgaonkar S, et al. rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells. Mol Cell (2011) 44(4):660-6. doi:10.1016/j.molcel.2011.09.017.
55. Liang XH, Liu Q, Fournier MJ. rRNA modifications in an intersubunit bridge of the ribosome strongly affect both ribosome biogenesis and activity. Mol Cell (2007) 28(6):965-77. doi:10.1016/j.molcel.2007.10.012.
56. Yoon A, Peng G, Brandenburger Y, Zollo O, Xu W, Rego E, et al. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science (2006) 312(5775):902-6. doi:10.1126/science.1123835.
57. Piekna-Przybylska D, Decatur WA, Fournier MJ. New bioinformatic tools for analysis of nucleotide modifications in eukaryotic rRNA. RNA (2007) 13(3):305-12. doi:10.1261/rna.373107.
58. Zebarjadian Y, King T, Fournier MJ, Clarke L, Carbon J. Point mutations in yeast CBF5 can abolish in vivo pseudouridylation of rRNA. Mol Cell Biol (1999) 19(11):7461-72.